Search for Clinical Trial Results

Sponsored By

Esophagitis - 42 Studies Found

Status Study
Completed Study Name: Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis
Condition:
  • Erosive Esophagitis
  • Reflux Esophagitis
  • Repeatedly Recurring Esophagitis
  • Relapsing Reflux Esophagitis Date: 2012-03-22
NOT_YET_RECRUITING Study Name: Validation in French of a Quality of Life Questionnaire for Patients With Eosinophilic Esophagitis in Pediatrics
Condition:
Date: 2025-08-02
Interventions: Measurement of the quality of life of patients with eosinophilic esophagitis by the PedsQL questionnaire eosinophilic esophagitis module
NOT_YET_RECRUITING Study Name: Esomeprazole and Radiation Induced Esophagitis
Condition: Radiation Esophagitis
Date: 2025-08-02
Interventions: Enrolled patients will receive 40 mg of esomeprazole (two pills of 20 mg strength of esomeprazole) once daily before breakfast for the entire duration
Completed Study Name: A Study to Investigate Safety and Tolerability of NDX-3315 in Healthy Participants and Patients With Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Date: 2025-08-02
Interventions: Oral solution
Completed Study Name: Zemaira Eosinophilic Esophagitis Pilot Study
Condition: Eosinophilic Esophagitis
Date: 2025-08-02
Interventions: Intravenous infusion at 120 mg/kg body weight dose/week for 12 weeks for a total of 12 infusions.
Completed Study Name: Imaging of the Esophagus Using a SECM Capsule
Condition: Eosinophilic Esophagitis
Date: 2025-08-02
Interventions: Subjects will swallow a SECM capsule and the SECM imaging will be performed
Completed Study Name: A Study of CDX-0159 in Patients With Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Date: 2025-08-02
Interventions: subcutaneous administration
Completed Study Name: A Study of Dexlansoprazole in Healing and Maintenance of Healed Erosive Esophagitis (EE) in Children
Condition: Erosive Esophagitis
Date: 2025-08-02
Interventions: Dexlansoprazole capsules
COMPLETED Study Name: Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Date: 2025-08-02
Interventions: 1-hour intravenous infusion
<<< Previous | Next >>>